QuantuMdx, The Technology Strategy Board (TSB) diagnostic news

QuantuMDx received £1.4 million ($2.2 million) from the TSB's Biocatalyst Fund for the biotech's Q-Cancer project. Under the project, the company aims to develop a genotyping tumor profiler that can p...